Investigating a hemagglutinin mediated molecular mechanism of avian influenza a virus host tropism

Active Project Grant Awarded Last action

Award ID
F31AI191745
Recipient
Awarding agency
Obligated
$149,190

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date 56% complete
Place of performance
Worcester, MA 01655, USA

Award details come from USAspending.gov.

About this award

The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services National Institutes of Health, awarded $149,190 to the University of Massachusetts Medical School on December 17, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) for a project grant (F31AI191745) to investigate hemagglutinin-mediated molecular mechanisms of avian influenza A virus host tropism.

The research examines how the hemagglutinin (HA) envelope glycoprotein of avian influenza A virus adapts to enable zoonotic transmission to humans. The project focuses on defining the pH and temperature dependence of HA's pre- to post-fusion conformational changes using single-molecule fluorescence resonance energy transfer (smFRET) techniques. Preliminary data demonstrate that HA head domains undergo conformational dynamics—shifting between fully caged and partially uncaged states—with equilibrium distributions that vary with pH. The work aims to establish a conformational phenotype for HA to determine how pH and temperature dependence govern host tropism, addressing a molecular mechanism gap in understanding zoonotic transmission of avian H5N1 strains to human cells.

Place of performance is Worcester, Massachusetts. The project period runs from December 17, 2025, through June 30, 2027.

Description

Abstract
Zoonotic transmission of avian influenza a virus (IAV) to humans poses a pandemic threat. Recent transmission of avian IAV to dairy cattle, and to dairy farm employees emphasizes the importance of identifying molecular mechanisms that regulate zoonotic events. IT is thought that the IAV envelope glycoprotein, hemagglutinin (HA), must adapt its receptor specificity to bind Α2,6-linked SA that predominates the human upper airway to initiate infection. However, recognition of Α2,6-linked SA by HA is insufficient for avian H5N1 iavs to enter human cells, indicating that other adaptations are necessary for zoonotic transmission to occur. Although evidence suggests that the PH and temperature sensitivity of HA are important factors that govern host tropism of IAV, a molecular mechanism that explains the temperature and PH dependence is missing. To define the PH and temperature dependence of has pre- to post-fusion conformational change, we first focused on visualizing conformational dynamics of HA with single-molecule fret (SMFRET). Preliminary data reveal that under neutral PH and room temperature conditions, the head domains of a/vietnam/1194/2004 (H5N1) (VN04) HA, HA1, undergo a breathing motion where the heads are either fully caged, or partially uncaged. At PH8.0 HA spends 50% of the time in the fully caged conformation and 50% of the time in the partially uncaged conformation. Decreasing the PH to 6.5 shifts the equilibrium to where HA spends 30% of the time in the fully caged conformation and 80% of the time in the partially uncaged conformation. These data allow US to establish a conformational phenotype for HA where can determine the PH and temperature dependence of a given conformational phenotype. Thus, the central hypotheses of this proposal are that (1) the regulation of the pre- to post-fusion conformational change of avian HA is differentially regulated by PH and temperature compared to human adapted HA and (2) this difference in regulation directly affects the fusogenic function of HA. Experiments performed in aim 1 will characterize the PH and temperature dependence of has conformational phenotype by monitoring conformational dynamics of HA at PH 8.0, PH 6.5, and PH 5.5 as well as at room temperature and 37°C. I will implement the SMFRET for three HA serotypes: a/vietnam/1194/2004 (H5N1) (VN04), a/california/07/2009 (H1N1) (CA09) and a/hong kong/1/1968 (H3N2) (HK68). Furthermore, mutations that alter PH and temperature stability will be characterized to evaluate a molecular mechanism that can explain the differences in the conformational phenotype between the different HA serotypes. Aim 2 will characterize the PH and temperature dependence on HA-mediated membrane fusion by monitoring the extent and rates of fusion of HA pseudo-typed virus with the three previously mentioned HA serotypes. Additionally, the same PH and temperature stability mutations will be used to assess their impact membrane fusion. Collectively, these data will reveal a mechanism that explains the zoonotic transmission potential of IAV and help improve genetic surveillance efforts to identify variants of concern.

Transactions

Action Obligated Date
Amendment $50,114
Amendment $49,538
Amendment $49,538
Amendment $0
Original award $0

Quick answers

Who received award F31AI191745?

F31AI191745 was awarded to University Of Massachusetts Medical School by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 17, 2025.

How much is award F31AI191745 worth?

$149,190 has been obligated on F31AI191745.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award